Filing Details

Accession Number:
0001209191-13-058670
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-26 17:01:04
Reporting Period:
2013-12-23
Filing Date:
2013-12-26
Accepted Time:
2013-12-26 17:01:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1066040 Jr E Francis Odonnell C/O Biodelivery Sciences Intl, Inc.
801 Corporate Center Drive, Suite 210
Raleigh NC 27607
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-12-23 100,000 $5.91 2,771,751 No 4 J Indirect By HCG II LLC
Common Stock Disposition 2013-12-23 50,000 $5.88 2,721,751 No 4 S Indirect By HCG II LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Indirect By HCG II LLC
No 4 S Indirect By HCG II LLC
Footnotes
  1. The subject shares, which were held indirectly by the Reporting Person through Hopkins Capital Group II, LLC, were involuntarily transferred by Hopkins Capital Group II, LLC to a lender of Hopkins Capital Partners, Inc. under a pledge and account control agreement between the lender and Hopkins Capital Partners, Inc. The lender exercised its rights to take title to such shares in exchange for a reduction in Hopkins Capital Partners, Inc.?s secured indebtedness equal to $5.91 per transferred share.
  2. These shares are owned by Hopkins Capital Group II, LLC, of which the Reporting Person is the Manager.
  3. On December 23, 2013, the Reporting Person sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $5.88. The highest sale price for the Common Stock was $5.95 per share and the lowest sale price was $5.86 per share.